col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


54 Results       Page 1

 [1] 
Wiley: Journal of Cellular and Molecular Medicine
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―19 LncRNAs expression profile in a family household cluster of COVID-19 patients Iulia Virginia Iancu, Carmen Cristina Diaconu, Adriana Plesa, Alina Fudulu, Adrian Albulescu, Ana Iulia Neagu, et al. (+11)
2 [GO] 2024―Feb―10 Genetic justification of COVID-19 patient outcomes using DERGA, a novel data ensemble refinement greedy algorithm Panagiotis G. Asteris, Amir H. Gandomi, Danial J. Armaghani, Markos Z. Tsoukalas, Eleni Gavriilaki, Gloria Gerber, et al. (+22)
3 [GO] 2023―Dec―16 Covid-19 and risk of acute pancreatitis: What beyond Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Mostafa M. Bahaa, Gaber El-Saber Batiha
4 [GO] 2023―Nov―15 Extracellular vesicle features are associated with COVID-19 severity Federica Caponnetto, Maria De Martino, Daniele Stefanizzi, Riccardo Del Sal, Ivana Manini, Feras Kharrat, et al. (+10)
5 [GO] 2023―Oct―26 A machine learning tool for the diagnosis of SARS-CoV-2 infection from hemogram parameters S. Gómez-Rojas, G. Pérez Segura, J. Ollé, G. Carreño Gómez-Tarragona, J. González Medina, J. M. Aguado, et al. (+3)
6 [GO] 2023―Oct―18 Calpain/calpstatin pathway in COVID-19: Role of dantrolene Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Maisra M. El-Bouseary, Athanasios Alexiou, Marios Papadakis, Gaber El-Saber Batiha
7 [GO] 2023―May―19 Severity of the Omicron SARS-CoV -2 variant compared with the previous lineages: A systematic review Maryam Arabi, Yousef Al-Najjar, Nada Mhaimeed, Mohammad A. Salameh, Pradipta Paul, Jamal AlAnni, et al. (+15)
8 [GO] 2022―Dec―20 COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management Cristiana Iosef, Claudio M. Martin, Marat Slessarev, Carolina Gillio-Meina, Gediminas Cepinskas, Victor K. M. Han, Douglas D. Fraser
9 [GO] 2022―Sep―09 BDA -410 inhibits SARS-CoV -2 main protease activity and viral replication in mammalian cells Christopher Schwake, Lindsay McKay, Anthony Griffiths, Christina Scartelli, Robert Flaumenhaft, Athar H. Chishti
10 [GO] 2022―May―19 Effect of ArtemiC in patients with COVID-19: A Phase II prospective study Elias Hellou, Jameel Mohsin, Ameer Elemy, Fahed Hakim, Mona Mustafa-Hellou, Shadi Hamoud
11 [GO] 2022―Apr―15 Stem Cell-based therapies for COVID-19-related acute respiratory distress syndrome Hoi Wa Ngai, Dae Hong Kim, Mohamed Hammad, Margarita Gutova, Karen Aboody, Christopher D. Cox
12 [GO] 2022―Apr―14 Even patients with mild COVID-19 symptoms after SARS-CoV-2 infection show prolonged altered red blood cell morphology and rheological parameters Marijke Grau, Lars Ibershoff, Jonas Zacher, Janina Bros, Fabian Tomschi, Katharina Felicitas Diebold, et al. (+2)
13 [GO] 2022―Mar―31 Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry Ibrahim El-Battrawy, Filomena Longo, Iván J. Núñez Gil, Mohammad Abumayyaleh, Barbara Gianesin, Vicente Estrada, et al. (+44)
14 [GO] 2022―Jan―22 Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks Panagiotis G. Asteris, Eleni Gavriilaki, Tasoula Touloumenidou, Evaggelia-Evdoxia Koravou, Maria Koutra, Penelope Georgia Papayanni, et al. (+35)
15 [GO] 2022―Jan―19 Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior COVID-19 Mihaela Chivu-Economescu, Coralia Bleotu, Camelia Grancea, Daniela Chiriac, Anca Botezatu, Iulia V. Iancu, et al. (+14)
16 [GO] 2021―Dec―30 Cardiovascular and haematological events post COVID-19 vaccination: A systematic review Dana Al-Ali, Abdallah Elshafeey, Malik Mushannen, Hussam Kawas, Ameena Shafiq, Narjis Mhaimeed, et al. (+13)
17 [GO] 2021―Dec―24 Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19 Li Liu, Ju-Fang Qin, Man-Zhen Zuo, Quan Zhou
18 [GO] 2021―Dec―14 The atomic portrait of SARS-CoV-2 as captured by cryo-electron microscopy Tudor Emanuel Fertig, Leona Chitoiu, George Terinte-Balcan, Victor-Eduard Peteu, Daciana Marta, Mihaela Gherghiceanu
19 [GO] 2021―Dec―11 A close-up view of dynamic biomarkers in the setting of COVID-19: Striking focus on cardiovascular system Aysa Rezabakhsh, Seyyed-Reza Sadat-Ebrahimi, Alireza Ala, Seyed Mohammad Nabavi, Maciej Banach, Samad Ghaffari
20 [GO] 2021―Dec―07 3D culture of cancer cells in alginate hydrogel beads as an effective technique for emergency cell storage and transportation in the pandemic era Batoul Alallam, May Kyaw Oo, Wisam Nabeel Ibrahim, Abd Almonem Doolaanea
21 [GO] 2021―Nov―12 ARB might be superior to ACEI for treatment of hypertensive COVID-19 patients Hong-Jin Zhao, Yan Li, De-Yu Wang, Hai-Tao Yuan
22 [GO] 2021―Nov―11 Association between non-alcoholic fatty liver disease with the susceptibility and outcome of COVID-19: A retrospective study Guyi Wang, Shangjie Wu, Chenfang Wu, Quan Zhang, Fang Wu, Bo Yu, et al. (+4)
23 [GO] 2021―Oct―23 Vaso-occlusive crisis in a patient with sickle cell trait and COVID-19 Luiz A. R. Freitas, Lilian V. S. Carvalho, Jonathan L. M. Fontes, Cassiana S. Souza, Reginaldo B. Santos, Lara T. Cardoso, et al. (+9)
24 [GO] 2021―Oct―11 Conquering the cytokine storm in COVID-19-induced ARDS using placenta-derived decidua stromal cells Behnam Sadeghi, Elham Roshandel, Ali Pirsalehi, Sepide Kazemi, Ghazaleh Sankanian, Mohammad Majidi, et al. (+7)
25 [GO] 2021―Jun―23 Interplay between SARS-CoV-2-derived miRNAs, immune system, vitamin D pathway and respiratory system Elham Karimi, Hanieh Azari, Maryam Yari, Ahmad Tahmasebi, Mehdi Hassani Azad, Pegah Mousavi
26 [GO] 2021―Jun―17 Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity Ding Ma, Shuwen Liu, Lili Hu, Qinyu He, Weiwei Shi, Dongliang Yan, et al. (+5)
27 [GO] 2021―May―25 Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient Chiara Agrati, Concetta Castilletti, Alessandra Sacchi, Francesca Colavita, Maria Rosaria Capobianchi, Vincenzo Puro, et al. (+3)
28 [GO] 2021―May―24 Targeting the glycans: A paradigm for host-targeted and COVID-19 drug design Fatemeh Pourrajab
29 [GO] 2021―May―10 Interplay between SARS-CoV-2 and human long non-coding RNAs Maryam Moazzam-Jazi, Hossein Lanjanian, Samaneh Maleknia, Mehdi Hedayati, Maryam S. Daneshpour
30 [GO] 2021―Mar―24 Risk stratification by long non-coding RNAs profiling in COVID-19 patients Jie Cheng, Xiang Zhou, Weijun Feng, Min Jia, Xinlu Zhang, Taixue An, et al. (+7)
31 [GO] 2021―Mar―18 Back to basics in COVID-19: Antigens and antibodies-Completing the puzzle Monica Neagu, Daniela Calina, Anca Oana Docea, Carolina Constantin, Tommaso Filippini, Marco Vinceti, et al. (+5)
32 [GO] 2021―Mar―11 Association of glycosylated haemoglobin HbA1c levels with outcome in patients with COVID-19: A Retrospective Study Shuai Yuan, Huaping Li, Chen Chen, Feng Wang, Dao Wen Wang
33 [GO] 2021―Mar―04 Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease Emad E. Khoury, Yara Knaney, Ahmad Fokra, Safa Kinaneh, Zaher Azzam, Samuel N. Heyman, Zaid Abassi
34 [GO] 2021―Feb―21 Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2 Jingliang Cheng, Ju Zhou, Shangyi Fu, Jiewen Fu, Baixu Zhou, Hanchun Chen, et al. (+2)
35 [GO] 2021―Jan―15 The role of SARS-CoV-2 target ACE2 in cardiovascular diseases Hanzhao Zhu, Liyun Zhang, Yubo Ma, Mengen Zhai, Lin Xia, Jincheng Liu, et al. (+2)
36 [GO] 2020―Dec―18 Mortality and pre-hospitalization use of low-dose aspirin in COVID-19 patients with coronary artery disease Shuai Yuan, Peng Chen, Huaping Li, Chen Chen, Feng Wang, Dao Wen Wang
37 [GO] 2020―Dec―16 T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research Ziwei Chen, Pinglang Ruan, Lili Wang, Xinmin Nie, Xuejun Ma, Yurong Tan
38 [GO] 2020―Nov―26 Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin Xingyue Qin, Chen Huang, Ka Wu, Yu Li, Xiao Liang, Min Su, Rong Li
39 [GO] 2020―Nov―20 Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID-19 Cosmin Andrei Cismaru, Gabriel Laurentiu Cismaru, Seyed Fazel Nabavi, Mostafa Ghanei, Claudia Cristina Burz, Seyed Mohammad Nabavi, Ioana Berindan Neagoe
40 [GO] 2020―Nov―04 Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19 Lin Yan, Bei Cai, Yi Li, Min-Jin Wang, Yun-Fei An, Rong Deng, et al. (+5)
41 [GO] 2020―Oct―03 Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19? Panagiotis Sarantis, Evangelos Koustas, Athanasios G. Papavassiliou, Michalis V. Karamouzis
42 [GO] 2020―Sep―28 Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis Tian-Ao Xie, Meng-Yi Han, Xiao-Rui Su, Hou-He Li, Ji-Chun Chen, Xu-Guang Guo
43 [GO] 2020―Sep―25 Naturally activated adaptive immunity in COVID-19 patients Xiaofang Yang, Tongxin Dai, Xiaobo Zhou, Hongbo Qian, Rui Guo, Lei Lei, et al. (+7)
44 [GO] 2020―Sep―19 STAT3 isoforms differentially affect ACE2 expression: A potential target for COVID-19 therapy Inbal Shamir, Mor Abutbul-Amitai, Haya Abbas-Egbariya, Metsada Pasmanik-Chor, Gideon Paret, Yael Nevo-Caspi
45 [GO] 2020―Sep―17 Pharmacological rationale for antihypertensive drug choice on COVID-19-affected patients: ACEI/ARB might not increase their susceptibility Hong-Jin Zhao, Xiao-Mei Yang, Ai-Hong Wang, Yan Li
46 [GO] 2020―Aug―31 The phenotypic changes of γδ T cells in COVID-19 patients Lei Lei, Hongbo Qian, Xiaofang Yang, Xingzhe Zhang, Dan Zhang, Tongxin Dai, et al. (+7)
47 [GO] 2020―Aug―20 Diseases with health disparities as drivers of COVID-19 outcome John T. Moore, William Pilkington, Deepak Kumar
48 [GO] 2020―Jul―26 The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients Hengzhi Du, Dao Wen Wang, Chen Chen
49 [GO] 2020―Jul―17 Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger! Solomon Habtemariam, Ioana Berindan-Neagoe, Cosmin Andrei Cismaru, Dedmer Schaafsma, Seyed Fazel Nabavi, Saeid Ghavami, et al. (+2)
50 [GO] 2020―Jul―08 Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2 Yunjin Li, Qiyue Xu, Lu Ma, Duojiao Wu, Jie Gao, Geng Chen, Hua Li
51 [GO] 2020―Jun―28 The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection Qiaoyan Shen, Xia Xiao, Aili Aierken, Wei Yue, Xiaojie Wu, Mingzhi Liao, Jinlian Hua
52 [GO] 2020―May―20 SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection Hua Li, Jue Pan, Yi Su, Beili Wang, Junbo Ge
53 [GO] 2020―Apr―22 Scientific research progress of COVID-19/ SARS-CoV-2 in the first five months Hua Li, Zhe Liu, Junbo Ge
54 [GO] 2020―Apr―13 G6PD and chloroquine: Selecting the treatment against SARS-CoV-2? Eva N. Kassi, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
 [1] 

54 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec